Drug intelligence / Profile preview

Shiyifang Yaojiu

Development stage: Unknown
Lead developer: First Affiliated Hospital of Guangxi University of Chinese Medicine
Administration: Topical

Overview

Shiyifang Yaojiu is a traditional Chinese medicinal liquor (medicated wine) developed by the First Affiliated Hospital of Guangxi University of Chinese Medicine. It is formulated based on traditional principles to treat acute closed soft tissue contusions, specifically targeting the 'Qi stagnation and blood stasis' syndrome. The preparation is intended for topical application to reduce swelling, alleviate pain, and promote the resolution of hematomas by improving local blood circulation. It is currently undergoing Phase II clinical evaluation in China to assess its efficacy and safety in patients with traumatic injuries.

Brand names: Shiyifang Yaojiu
Other names: 十一方药酒

Beyond the preview

Go deeper on Shiyifang Yaojiu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shiyifang Yaojiu.

Explore the full profile